文献速递类风湿关节炎

类风湿关节炎患者髋部骨折发生率及骨折后死亡风险相对于一般人群的研究

Incidence of and Risk of Mortality After Hip Fractures in Rheumatoid Arthritis Relative to the General Population.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-12-22

基于加拿大不列颠哥伦比亚省行政健康数据的纵向研究,纳入1997至2009年诊断的37616例类风湿关节炎(RA)患者及75213名年龄性别匹配的一般人群对照,随访至2014年。RA患者髋部骨折风险较对照高28%(IRR 1.28,95%CI 1.20-1.37),但骨折后1年和5年死亡风险与一般人群无差异。

要点

  • RA患者髋部骨折风险较年龄性别匹配的一般人群对照高28%(IRR 1.28,95%CI 1.20-1.37)。
  • RA患者骨折时平均年龄略低于对照(79.6±10.8岁 vs 81.6±9.3岁)。
  • 骨折后1年和5年死亡风险在RA与一般人群对照间无差异。

核心结论

  • RA患者较一般人群有更高的髋部骨折风险,但骨折后死亡风险不高于一般人群。
  • 观察到的髋部骨折相对风险不如既往报道那么高,可能反映了炎症治疗及骨质疏松及其危险因素管理的改善。

研究设计与样本

  • 基于人群的纵向研究,纳入1997至2009年诊断的RA患者37616例及一般人群年龄性别匹配对照75213名,随访至2014年,使用加拿大不列颠哥伦比亚省行政健康数据。
  • 髋部骨折结局依据ICD-9-CM编码820.0或820.2及ICD-10-Canada编码S72.0至S72.2识别,死亡结局在骨折后预设时间点(住院期间、90天、1年、5年)判定。
  • 计算RA与对照的髋部骨折发生率及发生率比(IRR),采用Cox比例风险模型比较骨折与死亡风险,采用logistic回归比较住院期间死亡风险。
  • 敏感性分析仅纳入接受改善病情抗风湿药治疗的RA患者,结果相似。

主要发现

  • RA组共识别1314例髋部骨折,累计360521人年;对照组共2083例髋部骨折,累计732249人年。
  • RA患者髋部骨折风险较对照高28%(IRR 1.28,95%CI 1.20-1.37)。
  • 骨折时平均年龄RA组为79.6±10.8岁,对照组为81.6±9.3岁。
  • 骨折后1年和5年死亡风险在RA与一般人群对照间无差异。
  • 仅纳入接受改善病情抗风湿药治疗的RA患者的敏感性分析结果相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Osteoporosis, a known complication of rheumatoid arthritis (RA), increases the risk of hip fracture, which is associated with high morbidity and mortality. Fracture risk estimates in patients with RA treated with contemporary treatment strategies are lacking. The objectives were (1) estimate age-specific and sex-specific incidence rates and compare the risk of hip fractures in RA relative to age-matched and sex-matched general population controls, and (2) compare the risk of all-cause mortality in RA and general population controls after hip fracture. METHODS: A longitudinal study of a population-based incident cohort of patients with RA diagnosed between 1997 and 2009, followed until 2014, with age-matched and sex-matched controls from the general population of British Columbia, using administrative health data. Hip fracture outcomes (International Classification of Diseases, Ninth Edition, Clinical Modification [ICD-9-CM] codes 820.0 or 820.2; ICD-10-Canada code S72.0 to S72.2) and mortality at predefined intervals after fracture (in hospital, 90 days, 1-year, 5-year) were identified. Hip fracture incidence rates for RA and controls, and incidence rate ratios (IRRs), were calculated. Cox proportional hazards models compared hip fracture and mortality risk in RA versus controls; logistic regression compared in-hospital mortality risk. RESULTS: Overall, 1,314 hip fractures over 360,521 person-years were identified in 37,616 individuals with RA and 2,083 over 732,249 person-years in 75,213 controls, yielding a 28% greater fracture risk in RA (IRR 1.28 [95% confidence interval 1.20-1.37]). Mean age at time of fracture was slightly younger for RA than controls (79.6 ± 10.8 vs 81.6 ± 9.3 years). Postfracture mortality risk at one-year and five-years did not differ between RA and general population controls. Results were similar in a sensitivity analysis including only individuals with RA who received disease-modifying antirheumatic drugs. CONCLUSION: People with RA had a greater risk of hip fractures, but no greater risk of mortality post fracture, than the general population. The relative risk of hip fractures observed was not as high as previously reported, likely reflecting better treatment of inflammation and management of osteoporosis and its risk factors.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Jones CA, Guy P, Xie H, et al. Incidence of and Risk of Mortality After Hip Fractures in Rheumatoid Arthritis Relative to the General Population. Arthritis Care Res (Hoboken). 2024. PMID: 39542830. doi:10.1002/acr.25466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。